HanaVax ^None

HanaVax is a drug discovery company that focuses on developing next-generation nasal vaccines. Their vaccines aim to induce both systemic and mucosal immunity, making them effective against respiratory infections. They use a cationized nanogel delivery system to encapsulate vaccine antigens and adjuvants, which efficiently delivers them to immunocompetent cells. This system generates a strong immune response, preventing the development of infectious diseases. HanaVax's goal is to promote the use of nasal vaccines globally to create a healthier society.